GC
DNLI icon

Gilbert & Cook’s Denali Therapeutics DNLI Stock Holding History

Gilbert & Cook’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Buy
11,179
+308
+3% +$6.33K 0.03% 197
2026
Q1 		$209K Buy
+10,871
New +$216K 0.03% 212

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gilbert & Cook's DNLI Position: Q2 2026 in Review

Gilbert & Cook increased its Denali Therapeutics (DNLI) stake by 2.8% in Q2 2026, buying an estimated $6.33K and bringing the position to 11,179 shares worth $288K. The position accounts for 0.03% of the portfolio, ranked #197.

Gilbert & Cook first reported a position in DNLI in Q1 2026 and has held it in 2 quarters since. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Gilbert & Cook held 11,179 shares of Denali Therapeutics worth $288K as of Q2 2026.
  • Gilbert & Cook bought 308 Denali Therapeutics shares in Q2 2026, an estimated $6.33K.
  • Denali Therapeutics made up 0.03% of Gilbert & Cook's portfolio in Q2 2026, its #197 holding.
  • Gilbert & Cook first reported a position in Denali Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Gilbert & Cook's 13F filing for Q2 2026, filed 28 Jul 2026.